
    
      Open non randomized, non controlled single center study on the pharmacokinetics of
      caspofungin in 20 consecutive ICU patients with severe sepsis or septic shock, requiring
      caspofungin therapy and PK-PD evaluation for the optimization of caspofungin therapy. The aim
      of this study is to describe the Caspofungin PK-PD alterations in a cohort of critically ill
      septic patients.
    
  